Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies
if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the
same subfield and year (this is the minimum needed to enter the top 1%, not the average
within it), or reaches the top citation threshold in at least one of its specific research
topics.
Citations per year, relative to R Veyrat R Veyrat (= 1×)
peers
Paul E. Slaton
Countries citing papers authored by R Veyrat
Since
Specialization
Citations
This map shows the geographic impact of R Veyrat's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by R Veyrat with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites R Veyrat more than expected).
This network shows the impact of papers produced by R Veyrat. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by R Veyrat. The network helps show where R Veyrat may publish in the future.
Co-authorship network of co-authors of R Veyrat
This figure shows the co-authorship network connecting the top 25 collaborators of R Veyrat.
A scholar is included among the top collaborators of R Veyrat based on the total number of
citations received by their joint publications. Widths of edges
represent the number of papers authors have co-authored together.
Node borders
signify the number of papers an author published with R Veyrat. R Veyrat is excluded from
the visualization to improve readability, since they are connected to all nodes in the network.
All Works
20 of 20 papers shown
1.
Veyrat, R, et al.. (1973). Increased plasma renin substrate concentration in human malignant hypertension.. PubMed. 37(4). 235–50.3 indexed citations
2.
Veyrat, R, et al.. (1971). Release of renin by human kidney slices, in vitro effect of angiotensin II, norepinephrine and aldosterone.. PubMed. 16(8). 792–4.13 indexed citations
3.
Grandchamp, A, et al.. (1970). 3. Measurement of sweat sodium and potassium excretion for evaluation of mineralocorticoid activity in patients with Addison's disease.. PubMed. 35(3). 201–16.1 indexed citations
Grandchamp, A, et al.. (1969). I. Measurement of sweat sodium and potassium excretion for evaluation of mineralocorticoid activity in normal subjects.. PubMed. 34(5). 367–85.2 indexed citations
6.
Veyrat, R, et al.. (1968). Un cas d'hypertension artérielle juvénile avec hypokaliémie et sécretion basse d'aldostérone (syndrome de Liddle). Schweizerische medizinische Wochenschrift. 98(19). 725–726.1 indexed citations
7.
Veyrat, R, et al.. (1968). [A case of juvenile arterial hypertension associated with hypokalemia and low aldosterone secretion (Liddle syndrome)].. PubMed. 98(19). 725–6.1 indexed citations
8.
Veyrat, R, et al.. (1967). [Inhibition of renin by potassium in the man].. PubMed. 47. 119–119.14 indexed citations
9.
Veyrat, R, et al.. (1967). [Inhibition of plasmatic renin activity by potassium].. PubMed. 73(4). 271–5.10 indexed citations
10.
Mantero, Franco, et al.. (1967). Effets d'une surcharge en d-aldostérone sur la composition corporelle, mesurée par dilution isotopique, et sur la rénine plasmatique d'un sujet normal.. Schweizerische medizinische Wochenschrift. 97(39).1 indexed citations
Veyrat, R, et al.. (1966). [Interrelations between potassium, renin and aldosterone].. PubMed. 46. 141–141.2 indexed citations
14.
Veyrat, R, J DECHAMPLAIN, R. Boucher, et al.. (1964). CRITERIA FOR SUCCESS OF SURGERY IN RENOVASCULAR HYPERTENSION.. PubMed. 77. 201–9.8 indexed citations
15.
Veyrat, R, et al.. (1962). [Selective inhibition of aldosterone secretion by a semi-synthetic heparinoid (Ro-1 8307)].. PubMed. 29. 543–9.1 indexed citations
16.
Veyrat, R, et al.. (1961). [Severe hypochromic megaloblastic anemia with hypersideremia and hemochromatosis].. PubMed. 91. 1215–7.2 indexed citations
17.
Veyrat, R, et al.. (1959). [Clinical and metabolic study of new diuretics of the sulfonamide group].. PubMed. 89. 1133–40.8 indexed citations
18.
Veyrat, R, et al.. (1959). [Study of conditions of non-response to diuretics].. PubMed. 26. 666–71.1 indexed citations
19.
Kapançi, Y & R Veyrat. (1959). [Pulmonary arteriosclerosis caused by arterial & arteriolar thromboses].. PubMed. 22(3). 392–7.1 indexed citations
20.
Veyrat, R. (1953). [Composition of unipolar electric potentials derived from the surface of the heart].. PubMed. 11(4). 395–422.1 indexed citations
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive
bibliographic database. While OpenAlex provides broad and valuable coverage of the global
research landscape, it—like all bibliographic datasets—has inherent limitations. These include
incomplete records, variations in author disambiguation, differences in journal indexing, and
delays in data updates. As a result, some metrics and network relationships displayed in
Rankless may not fully capture the entirety of a scholar's output or impact.